Biotech pioneer Leroy Hood has spent years outlining a vision of finding networks of proteins in the blood that can offer an early warning sign of cancer on the move. Now the startup that Hood and Caltech’s Jim Heath founded to pursue... Read more »
Multi-talented scientist Yoky Matsuoka is making it official: She won’t return to the University of Washington, choosing instead to focus on her new job as vice president of technology for Silicon Valley “smart thermostat” startup Nest.
It’s a loss for the... Read more »
As if they didn’t have enough headaches to deal with, here’s some fresh fear, uncertainty, and doubt for small-business IT guys: Employees are not going to stop hauling their smartphones to work, and you probably don’t have a good idea of just... Read more »
You can’t talk to a Googler for very long without hearing them recite the company’s mission statement: to organize the world’s information and make it universally accessible and useful. Not only does it sound noble, but it’s an all-purpose answer for... Read more »
[Updated and corrected, 10:15 am PT] Steve Jobs used to love being on stage, getting the audience in the palm of his hand. Famously, he’d say, “Oh, and one more thing,” to build suspense right before delivering some stunning... Read more »
Xconomy’s national biotech editor, Luke Timmerman, has won a national award for column-writing from the Society of American Business Editors and Writers. It’s the first national journalism award for Xconomy, which was founded in 2007 and now operates a six-city network... Read more »
The roller coaster known as Cell Therapeutics is back on the ascent today.
The Seattle-based biotech company (NASDAQ: CTIC) said its experimental lymphoma drug pixantrone (Pixuvri) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human... Read more »